1. Home
  2. TRVI vs ESQ Comparison

TRVI vs ESQ Comparison

Compare TRVI & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • ESQ
  • Stock Information
  • Founded
  • TRVI 2011
  • ESQ 2006
  • Country
  • TRVI United States
  • ESQ United States
  • Employees
  • TRVI N/A
  • ESQ N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • TRVI Health Care
  • ESQ Finance
  • Exchange
  • TRVI Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • TRVI 725.7M
  • ESQ 837.6M
  • IPO Year
  • TRVI 2019
  • ESQ 2017
  • Fundamental
  • Price
  • TRVI $7.01
  • ESQ $97.01
  • Analyst Decision
  • TRVI Strong Buy
  • ESQ Hold
  • Analyst Count
  • TRVI 10
  • ESQ 3
  • Target Price
  • TRVI $19.35
  • ESQ $103.00
  • AVG Volume (30 Days)
  • TRVI 2.0M
  • ESQ 72.8K
  • Earning Date
  • TRVI 11-05-2025
  • ESQ 10-23-2025
  • Dividend Yield
  • TRVI N/A
  • ESQ 0.72%
  • EPS Growth
  • TRVI N/A
  • ESQ 12.45
  • EPS
  • TRVI N/A
  • ESQ 5.39
  • Revenue
  • TRVI N/A
  • ESQ $126,841,000.00
  • Revenue This Year
  • TRVI N/A
  • ESQ N/A
  • Revenue Next Year
  • TRVI N/A
  • ESQ $27.16
  • P/E Ratio
  • TRVI N/A
  • ESQ $18.01
  • Revenue Growth
  • TRVI N/A
  • ESQ 12.91
  • 52 Week Low
  • TRVI $2.36
  • ESQ $58.69
  • 52 Week High
  • TRVI $8.78
  • ESQ $106.11
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 44.05
  • ESQ 49.24
  • Support Level
  • TRVI $7.09
  • ESQ $92.33
  • Resistance Level
  • TRVI $8.78
  • ESQ $100.87
  • Average True Range (ATR)
  • TRVI 0.43
  • ESQ 2.36
  • MACD
  • TRVI -0.07
  • ESQ -0.21
  • Stochastic Oscillator
  • TRVI 4.32
  • ESQ 49.63

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: